What is a white-label clinical trials listing?
A clinical trials listing platform is software that aggregates trial records from registries like ClinicalTrials.gov and sponsor feeds, lets prospective participants search by condition, phase, location, and eligibility criteria, runs pre-screening questionnaires, captures informed consent digitally, and routes qualified leads to trial sites with status tracking. A white-label version would be a licensed, rebrandable product you deploy under your brand without building it from scratch.
No such product exists. This is the clearest no-market case in healthcare: clinical trials recruitment is a specialized, regulated data problem, not a niche SaaS category. The real-world clinical trials software market serves sponsors, CROs (Contract Research Organizations), and academic medical centers through enterprise platforms that are sales-gated, purpose-built for their own operations, and not designed for resale as rebrandable licenses. No vendor in this space publishes white-label rate cards or reseller programs.
The regulatory stack is decisive and layered. Participant health data is Protected Health Information under HIPAA — any platform collecting pre-screening responses or health questionnaires needs a signed BAA, encryption, audit logs, and role-based access. Electronic records and consent signatures must comply with 21 CFR Part 11 (FDA regulation of electronic records and signatures in clinical research). Recruitment materials and consent flows require IRB (Institutional Review Board) review and approval. GDPR applies for EU-based trials. These are not check-the-box compliance features any general white-label app platform ships — they require deliberate architectural decisions and, in some contexts, independent validation. The nearest reusable foundation is Blaze.tech (blaze.tech), a white-label HIPAA app platform you can build on — but the trials-specific product itself must be custom-developed.
Who uses this
Pharmaceutical and biotech companies wanting a branded participant-recruitment portal distinct from ClinicalTrials.gov, CROs building a recruitment platform as a value-added service for sponsor clients, academic medical centers creating a unified trials-listing portal for their research portfolio, and patient advocacy organizations building condition-specific trial-matching tools for their communities.
There is no white-label clinical trials listing product with published pricing. The nearest options: Blaze.tech (blaze.tech) offers a white-label HIPAA app platform as a compliance foundation to build on (quote-based, verify current pricing). HIPAA Vault (hipaavault.com) provides HIPAA-compliant white-label hosting for custom builds. The public ClinicalTrials.gov API provides open trial registry data as an integration source, not a product. Specialized clinical trials recruitment platforms serving sponsors and CROs are enterprise SaaS with sales-gated pricing — not rebrandable (verify with vendors). DocVilla, expEDIum, and blueBriX are EHR and billing engines unrelated to trials listing.
Quick verdict
A white-label clinical trials listing is not a real option — there is no rebrandable product in this regulated niche. The only viable paths are: engage a specialized trials-recruitment enterprise platform under their terms (no rebranding), or commission a custom build on a HIPAA-compliant foundation that owns the listing, matching, and consent logic. The fixed $13K–$25K range covers a compliant listing and matching MVP; full 21 CFR Part 11 validated and IRB-coordinated systems typically require additional scoping beyond that range.
Go white-label if
This scenario does not realistically apply — no rebrandable clinical trials listing product exists for any budget or timeline.
Go custom if
You are building a trials-listing or recruitment portal, need to own the compliance logic and participant data, and want a HIPAA-compliant platform with ClinicalTrials.gov integration and pre-screening questionnaires as your branded product.
White-label vs off-the-shelf vs custom
The three real ways to run a Clinical Trials Listing. The highlighted cell wins each row.
| Aspect | White-label | Off-the-shelf SaaS | Custom build |
|---|---|---|---|
| Time to launch | Not applicable — no product exists | Enterprise CRO platforms: months of onboarding; not rebrandable | 6–10 weeks for a compliant listing MVP |
| Upfront cost | Not applicable — no product to license | Enterprise: sales-gated, expect five to six figures | $13,000–$25,000 fixed (MVP scope) |
| Monthly fees | Not applicable — no rebrandable option | Enterprise subscription, sales-gated and high | ~$100/mo hosting |
| Branding depth | No vendor to license — this row is moot | Enterprise platform brand only — no rebranding | 100% your brand, your compliance infrastructure |
| Regulatory compliance layer | No product — none available | Enterprise platforms have built-in trial-management compliance | Built to your specific HIPAA + 21 CFR Part 11 + IRB requirements |
| Code and data ownership | Not applicable | No ownership; participant data in vendor infrastructure | Full source code; participant data in your infrastructure |
| Integration with ClinicalTrials.gov | Not applicable — no product to integrate | Enterprise platforms typically integrate, not always rebrandable | Custom ClinicalTrials.gov API integration built to your spec |
| IRB and consent workflow flexibility | Not applicable | Fixed consent workflows in enterprise systems; adapting requires vendor engagement | Consent and IRB-submission flows designed to your protocol |
Swipe the table sideways to see all three paths.
Features a Clinical Trials Listing actually needs
Searchable trial listings from ClinicalTrials.gov and sponsor feeds
Must-haveAggregated trial data with search and filter by condition, phase (I–IV), geographic proximity, eligibility age range, and enrollment status — sourced from the public ClinicalTrials.gov API and supplemented by sponsor-provided protocol data.
Eligibility pre-screening questionnaires with match logic
Must-haveStructured questionnaires mapping respondent health status, demographics, and inclusion/exclusion criteria to specific trial protocols — filtering candidates before routing to trial sites to reduce site screening burden.
Informed consent capture with 21 CFR Part 11-aware audit trail
Must-haveDigital consent form delivery, signature capture, and immutable audit trail meeting 21 CFR Part 11 electronic-signature requirements — including timestamp, signer identity verification, and tamper-evident record storage.
Participant PHI handling with encryption and access controls
Must-haveHIPAA-compliant storage of participant personally identifiable and health information with encryption at rest and in transit, role-based access, and a signed BAA with all subprocessors — mandatory before collecting any pre-screening health data.
Sponsor and CRO portal for posting and managing trial records
Must-haveAuthenticated portal for sponsors and CRO staff to add and update trial postings, review referral pipeline, manage eligibility criteria, and track recruitment funnel metrics per trial.
Geolocation and site-finder for nearest participating sites
Must-haveMap-based site search showing the closest clinical trial locations to a participant's address or zip code — reducing the geographic barrier that accounts for a significant share of screen failures in recruiting.
Referral and lead routing to trial sites with status tracking
Must-haveAutomatic referral handoff to the appropriate trial site coordinator after pre-screening, with tracked status (referred, contacted, screened, enrolled, withdrawn) and follow-up automation for non-responses.
Saved searches and new-trial alerts for prospective participants
Must-haveRegistered participants save search criteria and receive email alerts when new matching trials open — increasing the long-term value of registered participants even for conditions with limited active trials today.
Multilingual listings and WCAG-accessible participant interface
Must-haveTrial descriptions and consent materials available in multiple languages, with WCAG 2.1 AA-compliant design — both are often requirements in IRB-approved recruitment plans for diverse patient populations.
Recruitment funnel and screen-to-enroll analytics
EdgeDashboard showing impressions, clicks, pre-screening completion rates, referral rates, screen failures, and enrolled-per-site metrics — the data sponsors and CROs use to allocate recruitment spend.
Signed BAA and SOC 2 Type II compliance documentation
EdgeFormal Business Associate Agreement covering all subprocessors, paired with a current SOC 2 Type II audit report — standard requirements for any enterprise pharma or academic medical center partnership.
The real cost of a white-label Clinical Trials Listing
Sticker price is never the whole story. Here is what you actually pay.
Setup fee
$5,000–$25,000
one-time onboarding
Monthly
$200–$1,000/mo
recurring, forever
Custom (one-time)
$13,000–$25,000 one-time
you own it
Run your own numbers
Drag the sliders to compare the total cost of ownership over your real operating horizon.
White-label total
$36.6K
over 36 months
Custom build total
$22.6K
incl. $100/mo hosting
You save
$14K
over 36 months
Assumptions: custom build uses the midpoint of your quoted range ($19K) plus $100/mo infrastructure. White-label figures interpolate between budget and premium vendors as you move the tier slider. Estimates for comparison only.
Revenue share is not applicable in this no-market context. Cost estimates above reflect a HIPAA-compliant custom build on Blaze.tech or similar infrastructure, not a white-label license that doesn't exist.
Hidden costs to budget for
Regulatory build cost — the real budget item
The dominant cost in any trials-listing build is the regulatory compliance layer: HIPAA-compliant infrastructure, 21 CFR Part 11-aware electronic consent with tamper-evident audit trails, and IRB-approved recruitment and consent workflows. None of this is shipped by any general app platform. Underestimating regulatory scope is the single most common reason trials-listing projects fail or run over budget.
IRB review and protocol approval timelines
Recruitment materials, eligibility criteria, and consent forms used in a trials-listing platform must be reviewed and approved by an Institutional Review Board before participant contact can begin. IRB review cycles can take 4–12 weeks for initial approval and additional cycles for amendments. This timeline is outside any vendor's or agency's control — plan for it in the project schedule.
ClinicalTrials.gov data sourcing and validation
The public ClinicalTrials.gov API provides open trial registry data but requires validation logic to handle incomplete, out-of-date, or sponsor-private trial records. Sponsor direct-feed integrations for non-public trials require individual data agreements with each sponsor or CRO. Budget for data-quality logic in the build, not just API connection.
21 CFR Part 11 system validation documentation
For formal FDA-regulated studies, electronic consent and data capture systems may require documented computer system validation (CSV) per 21 CFR Part 11 — a formal validation protocol, test scripts, and signed validation reports. This is a significant professional-services engagement beyond standard software development, typically quoted separately from the build itself.
Participant data export and PHI migration at exit
If you build on a hosting provider's HIPAA infrastructure (Blaze.tech, HIPAA Vault), clarify PHI export terms before signing: participant consent records and health questionnaire data must be exportable in a structured format with a defined timeline and cost at contract termination.
3-year cost reality
There is no white-label alternative to cost-compare against. The $13K–$25K fixed range covers a compliant clinical trials listing MVP: ClinicalTrials.gov integration, eligibility pre-screening, HIPAA-compliant participant data handling, digital consent with a basic audit trail, and a sponsor portal. Full 21 CFR Part 11 system validation (required for FDA-regulated studies) and IRB-coordinated consent workflow design are regulatory professional-services engagements that are scoped and quoted separately — they can add substantially to the project cost. Be honest with stakeholders about this distinction upfront rather than discovering it mid-project.
White-label launch roadmap
A clinical trials listing platform is one of the most compliance-intensive builds in healthcare. The regulatory phases run in parallel with — and often longer than — the software development phases.
Scope definition and regulatory assessment
2–4 weeksDefine what the MVP covers: public trial listings, eligibility pre-screening, referral routing, and basic consent capture. Engage a healthcare compliance consultant to assess which regulatory frameworks apply based on the specific trials and participant data collected — HIPAA scope, 21 CFR Part 11 applicability, and IRB requirements differ based on whether the platform serves industry-sponsored vs. investigator-initiated trials.
Watch out: The most expensive decision point: if the platform will be used in formal FDA-regulated clinical studies, 21 CFR Part 11 computer system validation requirements kick in and must be planned from the architecture phase — not added retroactively.
HIPAA infrastructure setup and BAA execution
2–3 weeksSelect and configure a HIPAA-compliant foundation — Blaze.tech (white-label HIPAA app platform), HIPAA Vault, or AWS HIPAA-eligible services. Execute BAAs with all subprocessors who will touch participant PHI: the hosting provider, email service, analytics platform, and any identity-verification service.
Watch out: BAA execution with the primary vendor is step one — but every downstream subprocessor that receives, stores, or processes PHI also needs a BAA in the chain. A gap here is a HIPAA violation, not a paperwork oversight.
Core platform development
4–8 weeksBuild the ClinicalTrials.gov API integration and trial data display layer, eligibility pre-screening questionnaire engine, participant registration and PHI collection with encryption, sponsor/CRO portal, geolocation site-finder, and referral routing with status tracking. RapidDev delivers this in 6–10 weeks on a HIPAA-compliant stack.
Watch out: ClinicalTrials.gov data quality varies significantly by trial. Build validation logic for required fields, enrollment status freshness, and eligibility criteria completeness — raw API data needs cleaning before display to participants.
IRB coordination and consent workflow review
4–12 weeks (runs in parallel)For any platform used in active participant recruitment for regulated studies, consent forms, eligibility questionnaires, and recruitment copy must be reviewed and approved by an IRB or ethics committee. Submit materials as early as possible — IRB cycles run independently of software development and are the most common project-timeline wildcard.
Watch out: IRB amendment cycles for consent form changes can take additional weeks each. Version-control consent documents carefully — deploying an unapproved consent version invalidates data collected under it.
Sponsor onboarding and pilot launch
2–4 weeksOnboard the first 2–3 sponsor or CRO clients with their trial records. Run a supervised soft launch with a limited participant pool before full public release. Collect screen-to-referral funnel data and tune the eligibility-matching logic based on early screening results.
Watch out: Participant referral quality — the ratio of referred participants who pass site screening — is the metric sponsors care about most. A platform sending poorly matched referrals loses sponsor trust faster than one with a smaller but better-matched referral volume.
Vendor red flags & what to ask
Before you sign, pressure-test every vendor with these. The wrong answer here costs you later.
Any vendor claiming to offer a white-label trials-listing product
No such product category exists. A vendor making this claim is either misrepresenting what they deliver (likely a generic health-data app platform or a CRO's internal tool they're re-pitching as white-label), or they have not built the regulatory features that make a trials-listing platform functional in practice.
Ask the vendor: “"Can you provide references from three clients who are currently operating a white-label clinical trials listing platform under their own brand using your product — with working ClinicalTrials.gov integration, 21 CFR Part 11-compliant consent capture, and IRB-approved recruitment flows?"”
BAA not covering 21 CFR Part 11 electronic records
A HIPAA BAA governs PHI handling — important, but insufficient for clinical research. Electronic consent signatures and trial data collected in FDA-regulated studies must also comply with 21 CFR Part 11. A platform with a BAA but no documented 21 CFR Part 11 controls may be compliant for HIPAA but inadequate for regulated research.
Ask the vendor: “"Beyond the BAA, what documented controls does your platform have for 21 CFR Part 11 compliance — specifically electronic signature audit trails, system access controls, and record integrity protections? Do you have a computer system validation (CSV) package available for sponsor review?"”
No IRB workflow experience or documentation
Recruitment materials, consent forms, and eligibility criteria deployed on a trials-listing platform for regulated studies must go through IRB review. A vendor unfamiliar with the IRB process will not flag this requirement, and the platform will be deployed with non-IRB-approved materials — invalidating collected data and creating regulatory exposure.
Ask the vendor: “"What is your standard process for coordinating with an IRB on consent form versions, and how does your platform handle consent form versioning so that participants who consented under version 1.0 are tracked separately from those who consented under version 2.0?"”
ClinicalTrials.gov integration without data validation
The ClinicalTrials.gov public API contains incomplete, outdated, and sometimes inaccurate trial records. A platform that passes raw registry data to participants without filtering for enrollment status, eligibility-criteria completeness, and study phase will generate frustrated participants and wasted site-screening resources.
Ask the vendor: “"How does your ClinicalTrials.gov integration handle trials with incomplete eligibility criteria, closed enrollment, or outdated status — and what data-quality validation runs before a trial record is displayed to a prospective participant?"”
PHI export terms absent from the hosting contract
Participant consent records and pre-screening health data are regulated PHI. If you can't export them in a structured, portable format at contract termination, you can't migrate to a new platform or fulfill research-record retention requirements.
Ask the vendor: “"At termination, in what format, on what timeline, and at what cost can I export all participant records, consent form signatures and timestamps, pre-screening responses, and audit trail data — and is this explicitly specified in the contract?"”
Fixed-price quote that buries regulatory scope in assumptions
Any agency or vendor quoting a fixed price for a trials-listing platform without explicitly scoping out 21 CFR Part 11 validation, IRB coordination, and multi-language consent support is giving you a number for a subset of the work. Discovering the full regulatory scope mid-project is how clinical tech projects double in cost.
Ask the vendor: “"Does your fixed-price quote include documented 21 CFR Part 11 computer system validation, IRB-coordinated consent workflow design, and multi-language consent form delivery — or are these scoped separately? What is your change-order policy if regulatory requirements expand during the project?"”
How far can you actually customize it?
Typical branding
- Custom domain for the participant-facing listing portal
- Logo, brand colors, and organization name on all participant-facing interfaces
- Branded email notifications (new trial alerts, consent confirmation, referral status updates)
- Sponsor and CRO portal branded with your organization's identity
- HIPAA-compliant hosting environment configured under your organization's cloud account
Typical limits
- ClinicalTrials.gov API data is public and owned by the registry — you display it, you don't own or control it
- IRB-approved consent forms are version-locked — you cannot modify them without a new IRB review cycle
- 21 CFR Part 11 audit trail records are immutable by design — you cannot edit or delete them after capture
- FDA regulatory guidance can change the compliance requirements for your platform independent of your development decisions
- Sponsor-private trial data requires individual data-sharing agreements with each sponsor organization
Custom unlocks
- ClinicalTrials.gov integration with custom data-validation and eligibility-filtering logic for your specific disease areas
- Proprietary eligibility pre-screening questionnaire engine with condition-specific branching logic
- IRB-coordinated digital consent workflow with version tracking and participant-level consent record storage
- Condition-specific trial-matching algorithms trained on your participant population data
- Sponsor portal with custom recruitment funnel analytics and site-performance dashboards
- Multilingual consent and recruitment materials with localization management built into the CMS
Which path fits you?
Patient advocacy organization building a condition-specific trial-matching tool
Custom fitsYou represent patients with a rare disease and want a branded portal that helps your community find clinical trials matching their condition, location, and eligibility. A custom build at $13K–$25K with ClinicalTrials.gov integration and pre-screening questionnaires is the most viable path — no off-the-shelf product serves this use case.
Academic medical center creating a unified trials-listing portal
Custom fitsYou run clinical research across 12 departments and want a branded portal where prospective participants can find and pre-screen for all active AMC trials in one place. Custom multi-department build with CRO-configured trial records and HIPAA-compliant pre-screening is the only workable architecture.
CRO building a recruitment platform as a sponsor value-add
Custom fitsYou manage clinical trials for pharma sponsors and want to offer a branded participant-recruitment portal as a service. Custom build owned by your organization — with sponsor portal access and referral routing — is the right path. Enterprise trials platforms are not designed for resale as a CRO service.
Pharma company wanting a branded participant recruitment portal
Custom fitsYou want to run participant recruitment for a specific therapeutic area under your company's brand, with custom eligibility pre-screening and informed consent that matches your IRB-approved protocol. Custom build on a HIPAA-compliant foundation is the only viable option.
Health tech startup building a condition-agnostic matching platform
Custom fitsYou are building a general-purpose clinical trials matching platform (ClinicalTrials.gov-powered) for consumer use. Custom build at $13K–$25K covers the MVP listing, pre-screening, and referral routing — understand that the regulated-consent and 21 CFR Part 11 validation layers are separate scope items that grow with your client base.
A white-label you actually own
Renting someone else's Clinical Trials Listingworks until it doesn't. RapidDev builds you a custom, fully-branded platform using AI-accelerated development — delivered in weeks, and yours to keep with zero recurring platform fees.
Discovery call (free)
30 minWe map exactly what your Clinical Trials Listing needs — the features white-label vendors gate behind upgrades, your branding, integrations, and users. You get a scoped, fixed-price quote within 48 hours.
AI-accelerated build
6–10 weeksOur engineers use Claude Code, Lovable, and custom AI tooling to build 3–5x faster than traditional agencies. You review progress in a live staging environment every week — never a black box.
Launch + handoff
1 weekWe deploy to your infrastructure, hand over the GitHub repo, wire up CI/CD, and walk your team through the codebase. You own 100% of it — no per-seat fees, no vendor lock-in.
What you get
Timeline
6–10 weeks
Investment
$13K–$25K fixed
Breakeven
No white-label alternative exists to calculate a breakeven against. The $13K–$25K fixed price covers a compliant listing and matching MVP. Full 21 CFR Part 11 computer system validation, IRB-coordinated consent workflow design, and multi-language consent materials are regulatory professional-services engagements quoted separately after a scoping call — they can add materially to total project cost depending on the regulatory requirements of your specific trial portfolio. RapidDev is transparent about this distinction: the MVP is fixed-price; the regulated-validation work is scoped separately.
30-min call. Fixed-price quote within 48 hours. No commitment.
Frequently asked questions
How much does a white-label clinical trials listing platform cost?
There is no white-label clinical trials listing product to license. The only viable path is a custom build. A compliant listing and pre-screening MVP costs $13,000–$25,000 fixed with RapidDev. Full 21 CFR Part 11 system validation and IRB-coordinated consent workflows are additional regulatory professional-services work quoted separately after a scoping call — these can add substantially to total cost depending on the regulated scope of your trials.
How fast can I launch a branded clinical trials listing platform?
Software development takes 6–10 weeks. The regulatory phases run in parallel and often take longer: IRB review cycles run 4–12 weeks per submission, BAA execution with subprocessors takes 2–3 weeks, and 21 CFR Part 11 system validation (if required) requires documented validation protocols that add weeks. Realistically, plan for a 3–6 month timeline from project start to compliant go-live.
What regulations apply to a clinical trials listing platform?
HIPAA applies to any collection of participant health information during pre-screening. 21 CFR Part 11 applies to electronic records and signatures used in FDA-regulated clinical studies — including digital consent signatures. IRB oversight applies to recruitment materials and consent forms. GDPR applies for EU-based trial participants. These are not optional depending on the use case — if your platform collects health information from prospective participants for regulated studies, all of the above apply.
Do I own participant data on a custom-built trials listing platform?
Yes, if you build on infrastructure you control. Participant consent records and pre-screening health data are regulated PHI — but on a custom build with HIPAA-compliant hosting (Blaze.tech, HIPAA Vault, or AWS HIPAA-eligible services) configured under your account, you own and control the data. Contrast this with any enterprise SaaS platform where participant data is in the vendor's system and subject to their export and termination terms.
Can I build a clinical trials listing platform on ClinicalTrials.gov data?
Yes. ClinicalTrials.gov provides a public API (clinicaltrials.gov/api) with open access to registered trial data. You can integrate this into a custom platform to power searchable trial listings. The integration requires data-quality validation logic — raw registry data includes incomplete, out-of-date, and closed-enrollment records that need filtering before display to participants. Sponsor-private trial data requires direct data-sharing agreements with individual sponsors beyond what the public API provides.
Can RapidDev build a custom clinical trials listing platform?
Yes. RapidDev builds custom clinical trials listing platforms in 6–10 weeks for $13,000–$25,000 fixed — including ClinicalTrials.gov integration, eligibility pre-screening questionnaires, HIPAA-compliant participant data handling, referral routing with status tracking, and a sponsor and CRO portal. The fixed price covers the compliant listing MVP. Full 21 CFR Part 11 system validation and IRB-coordinated consent workflows are scoped separately based on your specific regulatory requirements. Book a free scoping call at rapidevelopers.com.
What is the difference between a clinical trials listing platform and a clinical trial management system (CTMS)?
A clinical trials listing platform is participant-facing: it aggregates public and sponsor-provided trial records, helps prospective participants find matching trials, runs pre-screening questionnaires, captures consent, and routes referrals to site coordinators. A CTMS is site-facing: it manages the operational conduct of a trial — protocol tracking, subject enrollment and visit scheduling, adverse event reporting, and regulatory document management. These are adjacent but distinct systems; many research organizations need both, and they can share participant data via API.
Own your Clinical Trials Listing, don't rent it
- Delivered in 6–10 weeks
- You own 100% of the code
- No monthly platform fees
30-min call. No commitment.